Mitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced

Related Experiment Video

Updated: Oct 27, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

J H Yeh1, S C Hsu, S H Han

  • 1Graduate Institute of Microbiology and Immunology, National Yang-Ming University, Taipei 11217, Taiwan.

The Journal of Experimental Medicine
|November 17, 1998
PubMed

Insights

Mitogen-activated protein kinase kinase (MKK) activation inhibits Fas-mediated cell death by upregulating FLIP, a Fas-associated death domain (FADD) inhibitor. This pathway regulates apoptosis in various cell types.

Area of Science:

  • Cellular Biology
  • Immunology
  • Molecular Biology

Background:

  • Fas and FADD are crucial for cell homeostasis and regulating cell death.
  • Fas-mediated apoptosis is vital for numerous physiological processes.
  • T lymphocyte activation by Concanavalin A (Con A) suppresses Fas-mediated cell death.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which Con A activation inhibits Fas-mediated apoptosis.
  • To identify the specific signaling pathways involved in antagonizing Fas-triggered cell death.
  • To understand the role of mitogen-activated protein (MAP) kinase kinase (MKK) in this process.

Main Methods:

  • T lymphocyte activation using Concanavalin A (Con A).
  • Analysis of downstream signaling pathways, focusing on MAP kinase kinase (MKK).
  • Investigation of apoptosis markers, including FADD and caspase-3, and the expression of FLIP.

Main Results:

  • MKK activation was identified as the primary pathway antagonizing Fas-triggered cell death following Con A stimulation.
  • MKK1 specifically suppressed FADD-induced apoptosis, indicating early antagonism in the apoptotic cascade.
  • MKK1 activation led to increased expression of FLIP, a known inhibitor of FADD.
  • Inhibition of FLIP induction abrogated MKK1's effect, confirming FLIP's role in mediating the suppression of FADD-induced cell death.

Conclusions:

  • MAP kinase activation provides a general mechanism to attenuate death receptor-initiated apoptotic signals.
  • FLIP acts as a key mediator through which MKK1 suppresses FADD-dependent apoptosis.
  • This finding sheds light on the regulation of apoptosis in both normal and transformed cells.

More Related Videos

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...